ID

29055

Beschrijving

Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage

Trefwoorden

Versies (5)
  1. 5/10/17 5/10/17 -
  2. 22/2/18 22/2/18 -
  3. 22/2/18 22/2/18 -
  4. 22/2/18 22/2/18 -
  5. 17/9/21 17/9/21 -
Houder van rechten

gsk

Geüploaded op

22 de febrero de 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Ropinirole Case Report Form GSK RRL100013

Engels

INVESTIGATIONAL PRODUCT

9 Formulieren  
Investigational Product
Beschrijving

Investigational Product

Alias
UMLS CUI-1
C0304229
Planned timepoint
Beschrijving

Planned timepoint

Datatype

integer

Alias
UMLS CUI [1]
C2348792
Blinded dose level
Beschrijving

Blinded dose level

Datatype

integer

Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C0304229
Start Date
Beschrijving

Start Date

Datatype

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0304229
Stop Date
Beschrijving

Stop Date

Datatype

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C0304229
IP Container No. 1
Beschrijving

IP Container No 1

Datatype

text

Alias
UMLS CUI [1,1]
C0180098
UMLS CUI [1,2]
C0304229
IP Container No. 2
Beschrijving

IP Container No 2

Datatype

text

Alias
UMLS CUI [1,1]
C0180098
UMLS CUI [1,2]
C0304229
Has the subject missed investigational product for >2 consecutive days
Beschrijving

Has the subject missed investigational product for >2 consecutive days

Datatype

boolean

Alias
UMLS CUI [1]
C0457454
Average number of hours between early and late dose
Beschrijving

Average number of hours between early and late dose

Datatype

text

Terug naar het begin van de pagina

Similar models

INVESTIGATIONAL PRODUCT

9 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Investigational Product
C0304229 (UMLS CUI-1)
Item
Planned timepoint
integer
C2348792 (UMLS CUI [1])
Planned timepoint
Code List
Planned timepoint
CL Item
Baseline (1)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
Day 3 (2)
(Comment:en)
CL Item
Vital signs (3)
C0518766 (UMLS CUI-1)
(Comment:en)
Blinded dose level
Item
Blinded dose level
integer
C0178602 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
IP Container No 1
Item
IP Container No. 1
text
C0180098 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
IP Container No 2
Item
IP Container No. 2
text
C0180098 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Has the subject missed investigational product for >2 consecutive days
Item
Has the subject missed investigational product for >2 consecutive days
boolean
C0457454 (UMLS CUI [1])
Average number of hours between early and late dose
Item
Average number of hours between early and late dose
text
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial